Medidata
4 known investors
Find your way into Medidata
Sign up to see every warm intro you have to Medidata
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Medidata team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Medidata is a clinical trial software platform that serves pharmaceutical, biotech, and healthcare organizations conducting clinical research. It provides end-to-end trial management, patient data analytics, and regulatory compliance solutions across thousands of trials and millions of patients globally.
AI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHealthtechMedical DevicesSaaS
Founders & leadership
Investors · 4
Cota Capitallisted by Cota CapitalSan Francisco
How we know: Cota Capital's portfolio page · Not right? Tell us
Insight Partnerslisted by Insight PartnersNew York · $120M – $350M
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
Optum Ventureslisted by Optum VenturesBoston
How we know: Optum Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Medidata do?
- Medidata is a clinical trial software platform that serves pharmaceutical, biotech, and healthcare organizations conducting clinical research. It provides end-to-end trial management, patient data analytics, and regulatory compliance solutions across thousands of trials and millions of patients globally.
- Who founded Medidata?
- Medidata was founded by Tarek Sherif.
- Who are Medidata's investors?
- Medidata's investors include Cota Capital, Insight Partners, Optum Ventures, McKesson Ventures.




